Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
. 2014 Jan 30;58(1):2292.
doi: 10.4081/ejh.2014.2292.

Ontogenic development of corticotrophs in fetal buffalo (Bubalus bubalis) pituitary gland

Affiliations

Ontogenic development of corticotrophs in fetal buffalo (Bubalus bubalis) pituitary gland

M A Sandhu et al. Eur J Histochem. .

Abstract

To evaluate the subpopulation of corticotrophs in developing buffalo (Bubalus bubalis) fetus, recovered pituitary glands (n=6 per group) from late first, second and third gestational female buffalo dams. The corticotrophs were identified by using specific antibodies against proopiomelanocortin (POMC) and adrenocorticotrophic hormone (ACTH) through immunohistochemistry. There was a significant (P≤0.05) increase of immunoreactive (ir) ir-ACTH cells during late 2nd trimester while, ir-POMC cells were more (P≤0.05) at late 3rd trimester of gestation as compared to other age groups. The quantity of co-localized cells for POMC and ACTH was significantly (P≤0.05) greater at the end of 1st gestation rather than 2nd and 3rd gestational fetal adenohypophyseal cells. This study is the first to demonstrate co-localization of POMC+ACTH and the affect of gestational age on the expression of these cells in buffalo fetus adenohypophysis.

PubMed Disclaimer

Figures

Figure 1.
Figure 1.
Immunofluorescent staining for ACTH (Cy3) and POMC (Cy2) at 600x. Images from first (A), second (B) and third (C) trimester of gestation male buffalo fetus pituitary gland demonstrating double immunofluorescent staining for ACTH and POMC. Dotted arrow shows co-localization of ACTH and POMC. Normal arrow shows POMC in cells and round head arrow shows ACTH in cells. Scale bars: 20 µm.
Figure 2
Figure 2
Immunohistochemical images of buffalo fetus anterior pituitary gland during first, second and third trimester of gestation. (A; ACTH, B; POMC, C; co-localization of ACTH and POMC) at the age of 3 month fetus, (D; ACTH, E; POMC, F; co-localization of ACTH and POMC) at the age of 6 months, (G; ACTH, H; POMC, I; co-localization of ACTH and POMC) at 9 months of fetus age. Blue arrow shows individual cells having ACTH. White arrow shows individual cells having POMC granules, while yellow arrow shows the evidence of ACTH and POMC co-localization (yellow cells) in specific cell. Magnification: 400x.
Figure 3
Figure 3
Mean ± SEM proportion of corticotroph cells subpopulation at 3 months (plane white), 6 months (plane gray) and 9 months of gestation (white, hatched) fetuses. A-C, superscript letters indicate significant differences between animal age groups or between cell types (P≤0.05).

Similar articles

Cited by

References

    1. Fowden AL, Li J, Forhead AJ. Glucocorticoids and the preparation for life after birth: are there long-term consequences of the life insurance? P Nutr Soc 1998;57: 113-22 - PubMed
    1. Norman LJ, Lye SJ, Wlodek ME, Challis JR. Changes in pituitary responses to synthetic ovine corticotrophin releasing factor in fetal sheep. Can J Physiol Pharm 1985;63: 1398-403 - PubMed
    1. Farrand K, McMillen IC, Tanaka S, Schwartz J. Subpopulations of corticotrophs in the sheep pituitary during late gestation: effects of development and placental restriction. Endocrinology 2006;147:4762-71 - PubMed
    1. Carr GA, Jacobs RA, Young IR, Schwartz J, White A, Crosby S, et al. Develop-ment of adrenocorticotropin-(1-39) and precursor peptide secretory responses in the fetal sheep during the last third of gestation. Endocrinology 1995;136:5020-27 - PubMed
    1. Jones CT, Roebuck MM. ACTH peptides and the development of the fetal adrenal. J Steroid Biochem 1980;12:77-82 - PubMed

Substances

LinkOut - more resources